TD Cowen Reiterates Hold Rating on Avidity Biosciences (RNA) Nov 12, 2025 06:39AM
TD Cowen Downgrades Avidity Biosciences (RNA) to Hold Oct 29, 2025 02:27AM
Avidity Biosciences closes $690M stock offering Sep 15, 2025 04:01PM
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Sep 15, 2025 04:01PM
Avidity Biosciences prices $600 million stock offering at $40 per share Sep 11, 2025 07:56PM


Sep 11, 2025 07:56PM Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
Sep 10, 2025 04:01PM Avidity Biosciences plans $500 million stock offering
Sep 10, 2025 04:01PM Avidity Biosciences Announces Proposed Public Offering of Common Stock
Sep 10, 2025 10:07AM TD Cowen Reiterates Buy Rating on Avidity Biosciences (RNA)
Jun 24, 2025 09:40AM TD Cowen's Best Smidcap Ideas 2025
Feb 25, 2025 09:00AM Avidity Biosciences to Participate in Upcoming Investor Conferences
Nov 13, 2024 04:41PM Form SC 13G/A Avidity Biosciences, Filed by: Cowen Financial Products LLC
Oct 21, 2024 08:27AM Avidity Biosciences (RNA) PT Raised to $78 at TD Cowen
Oct 4, 2024 07:26AM TD Cowen Reiterates Buy Rating on Avidity Biosciences (RNA)
Aug 19, 2024 09:00AM Avidity Biosciences Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Aug 15, 2024 06:17AM Avidity Biosciences Inc. (RNA) Prices Upsized 7.32M Share Offering at $41/sh
Aug 14, 2024 08:30PM Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
Aug 13, 2024 04:01PM Avidity Biosciences Inc. (RNA) Announces Proposed $250M Share Offering
Aug 13, 2024 04:01PM Avidity Biosciences Announces Proposed Public Offering of Common Stock
Jun 25, 2024 10:27AM TD Cowen Reiterates Buy Rating on Avidity Biosciences (RNA)
Jun 17, 2024 04:05PM Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Jun 14, 2024 09:00AM Avidity Biosciences to Participate in Upcoming Investor Conference
Jun 13, 2024 08:00PM Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
Jun 12, 2024 04:01PM Avidity Biosciences (RNA) Announces Proposed $300M Share Offering
Jun 12, 2024 04:01PM Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock
Feb 27, 2024 09:00AM Avidity Biosciences to Participate in Upcoming Investor Conferences
Feb 2, 2024 12:09PM Form SC 13G/A Avidity Biosciences, Filed by: Cowen Financial Products LLC
Mar 1, 2023 04:05PM Avidity Biosciences to Participate in Upcoming Investor Conference
Jan 11, 2023 11:51AM Form SC 13G/A Avidity Biosciences, Filed by: Cowen Financial Products LLC
Dec 16, 2022 05:49AM Avidity Biosciences (RNA) Prices Upsized 12M Share Offering at $17.25/sh
Dec 15, 2022 07:37PM Avidity Biosciences, Inc. Announces Pricing of Upsized Public Offering of Common Stock
Dec 15, 2022 07:00AM Avidity Biosciences Inc. (RNA) Announces Proposed $150M Share Offering
Dec 15, 2022 07:00AM Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock
Aug 18, 2022 03:38PM Form SC 13G Avidity Biosciences, Filed by: Cowen Financial Products LLC
Mar 3, 2022 06:21AM Cowen Reiterates Outperform Rating on Avidity Biosciences (RNA)
Feb 11, 2022 04:05PM Avidity Biosciences to Participate in Upcoming Investor Conferences
Aug 4, 2021 05:30AM Avidity Biosciences Inc. (RNA) Prices 8M Share Offering at $18/sh
Aug 3, 2021 09:16PM Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
Aug 2, 2021 04:01PM Avidity Biosciences Inc. (RNA) Announces $100M Proposed Public Offering of Common Stock
Aug 2, 2021 04:01PM Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock
Jul 7, 2020 06:26AM UPDATE: Cowen Starts Avidity Biosciences (RNA) at Outperform
Jun 16, 2020 04:01PM Avidity Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jun 12, 2020 11:42AM Avidity Biosciences (RNA) IPO Opens 47% Higher
Jun 12, 2020 05:50AM Avidity Biosciences Inc. (RNA) Prices 14.4M Share IPO at $18/Sh
Jun 11, 2020 08:54PM Avidity Biosciences Announces Pricing of Initial Public Offering
Jul 23, 2013 10:43AM Notable Analyst Rating Changes 07/23: (TSS) (BHI) (ABX) Upgraded; (QSII) (BNNY) (ISIS) Downgraded